Prospective Investigation of Cirrhotic Cardiomyopathy in Humans | stella

Learn Data Labs For Researchers Find trials matched to me

Learn Data Labs For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prospective Investigation of Cirrhotic Cardiomyopathy in Humans | stella

Back to Cirrhotic Cardiomyopathy trials

Recruiting

Plain-English translation of NCT07658222 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Trial locations(2 sites)

United States

Vanderbilt University Medical Center, Nashville, Tennessee

UT Southwestern Medical Center, Dallas, Texas

Key details

Sponsor

Vanderbilt University Medical Center

Collaborators

National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~440 participants

Started

January 2026

Primary completion

June 2030

Age range

18 Years and older

Last updated on clinicaltrials.gov in June 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Manhal Izzy, MD

Vanderbilt University Medical Center

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.